Related Experiment Video

Updated: Mar 20, 2026

Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management
05:35

Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management

Published on: January 19, 2024

1.6K

Development of a Web-Based Decision Support Tool to Operationalize and Optimize Management of Hyperbilirubinemia in

Jonathan P Palma1, Yassar H Arain2

  • 1Division of Neonatal and Developmental Medicine, Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA; Department of Clinical Informatics, Stanford Children's Health, 4100 Bohannon Drive, Menlo Park, CA 94025, USA.

Clinics in Perinatology
|May 29, 2016
PubMed

Insights

Premie BiliRecs automates hyperbilirubinemia management for preterm infants. This clinical decision support tool standardizes care based on guidelines and generates evidence for future recommendations.

Area of Science:

  • Neonatal Medicine
  • Clinical Informatics
  • Evidence-Based Practice

Background:

  • Hyperbilirubinemia is a common condition in preterm infants.
  • Management of hyperbilirubinemia in moderately preterm infants (<35 weeks gestational age) relies on expert consensus guidelines.
  • Current guideline implementation can be variable.

Purpose of the Study:

  • To introduce Premie BiliRecs, a novel electronic clinical decision support tool.
  • To operationalize and automate existing expert consensus-based guidelines for hyperbilirubinemia management.
  • To facilitate the generation of new practice-based evidence for future guideline development.

Main Methods:

  • Development of an electronic clinical decision support tool (Premie BiliRecs).
  • Integration of current expert consensus-based guidelines into the tool's algorithm.
  • Design for automated data capture to support evidence generation.

Main Results:

  • Premie BiliRecs provides a novel, automated approach to managing hyperbilirubinemia.
  • The tool standardizes the application of current clinical guidelines.
  • The system is designed to collect data for future research and guideline refinement.

Conclusions:

  • Premie BiliRecs offers a valuable tool for improving hyperbilirubinemia management in moderately preterm infants.
  • Automation of guidelines enhances consistency and efficiency of care.
  • The tool has the potential to contribute to the evolution of clinical practice through evidence generation.

Keywords:
BiliToolClinical decision support (CDS)Electronic medical record (EMR)Neonatal preterm hyperbilirubinemiaPractice-based evidencePremie BiliRecs (PBR)

More Related Videos

Improving IV Insulin Administration in a Community Hospital12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

19.5K
Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

8.2K

Related Concept Videos

Health Information Technology and Healthcare Information System01:30

Health Information Technology and Healthcare Information System

Health Information Technology (HIT)
Health Information Technology, commonly called HIT, integrates advanced information systems and technology in healthcare settings. Its primary functions include:
3.6K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
315
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
705
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
249